MacTavish, R.; Slatculescu, A.; Ermacora, D.; Vukovojac, K.; Noth, T.; Ward, N.; Laskoski, K.; Fleming, D.; Manoharan, B.; Laroche, J.;
et al. National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥50 Years in Canada. Vaccines 2026, 14, 26.
https://doi.org/10.3390/vaccines14010026
AMA Style
MacTavish R, Slatculescu A, Ermacora D, Vukovojac K, Noth T, Ward N, Laskoski K, Fleming D, Manoharan B, Laroche J,
et al. National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥50 Years in Canada. Vaccines. 2026; 14(1):26.
https://doi.org/10.3390/vaccines14010026
Chicago/Turabian Style
MacTavish, Robert, Andreea Slatculescu, Dylan Ermacora, Katarina Vukovojac, Tanner Noth, Natalie Ward, Kathleen Laskoski, Daniela Fleming, Baanu Manoharan, Julie Laroche,
and et al. 2026. "National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥50 Years in Canada" Vaccines 14, no. 1: 26.
https://doi.org/10.3390/vaccines14010026
APA Style
MacTavish, R., Slatculescu, A., Ermacora, D., Vukovojac, K., Noth, T., Ward, N., Laskoski, K., Fleming, D., Manoharan, B., Laroche, J., & Fall, A.
(2026). National Near Real-Time Vaccine Effectiveness Against COVID-19 Severe Outcomes Using the Screening Method Among Older Adults Aged ≥50 Years in Canada. Vaccines, 14(1), 26.
https://doi.org/10.3390/vaccines14010026
